Simply Wall St has raised its fair value estimate for Viatris to $18.50 per share from $17.94, reflecting updated assumptions after the company's first-quarter results and pipeline progress. The revision incorporates a revenue growth assumption of 1.84%, down from 2.00%, a profit margin expectation of 4.92%, up from 4.50%, a future P/E multiple of 34.43x, down from 36.72x, and a discount rate of 7.24%, up from 7.11%. Separately, Barclays lifted its price target to $22 from $17 and maintained an Overweight rating, citing strong Q1 execution and an expected slate of product approvals this year that could help close the revenue growth gap to peers and support a higher valuation multiple over time.
Viatris IncFair value estimate raised and Barclays lifts price target to $22, citing strong Q1 execution and product approvals.
Barclays PLC